Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1093/clinchem/hvaa264 http://scihub22266oqcxt.onion/10.1093/clinchem/hvaa264 33279984!7799201!33279984     free     free     free       Clin+Chem 2021 ; 67 (1): 70-78 Nephropedia Template TP {{tp|p=33279984|t=2021. Implementation of High-Sensitivity and Point-of-Care Cardiac Troponin Assays into Practice: Some Different Thoughts |pdf=|usr=}}{{33279984}} gab.com Text Implementation of High-Sensitivity and Point-of-Care Cardiac Troponin Assays into Practice: Some Different Thoughts JO: Clin Chem http://www.kidney.de/pget.php?&tw=1&pmid=33279984 #FOAvip BACKGROUND: The primary role of the International Federation of Clinical Chemistry (IFCC) Committee on Clinical Application of Cardiac Bio-Markers (C-CB) is to provide educational materials about cardiac biomarker use, emphasizing high-sensitivity cardiac troponin assays. CONTENT: This mini-review, regarding high-sensitivity cardiac and point-of-care troponin assays, addresses 1) new IFCC C-CB/AACC Academy laboratory practice recommendations; 2) new and updated concepts from the Fourth Universal Definition of Myocardial Infarction; 3) the role of point-of-care assays in practice and research; 4) regulatory challenges concerning point-of-care assays; e) testing in the COVID-19 world. SUMMARY: Implementation of high-sensitivity cardiac troponin assays makes a difference now and into the future in clinical practice and research. Providing point-of-care high-sensitivity cardiac troponin assays and optimizing studies to allow clearance of these assays by regulatory agencies, in a timely fashion, may provide improved patient management and outcomes. Twit Text FOAVip Implementation of High-Sensitivity and Point-of-Care Cardiac Troponin Assays into Practice: Some Different Thoughts ????Clin Chem http://www.kidney.de/pget.php?&tw=1&pmid=33279984 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33279984 #FOAvip English Wikipedia <ref>{{Cite pmid|33279984}}</ref> Implementation of High-Sensitivity and Point-of-Care Cardiac Troponin Assays into Practice: Some Different Thoughts #MMPMID33279984 Apple FS; Fantz CR; Collinson PO Clin Chem 2021[Jan]; 67 (1): 70-78 PMID33279984show ga BACKGROUND: The primary role of the International Federation of Clinical Chemistry (IFCC) Committee on Clinical Application of Cardiac Bio-Markers (C-CB) is to provide educational materials about cardiac biomarker use, emphasizing high-sensitivity cardiac troponin assays. CONTENT: This mini-review, regarding high-sensitivity cardiac and point-of-care troponin assays, addresses 1) new IFCC C-CB/AACC Academy laboratory practice recommendations; 2) new and updated concepts from the Fourth Universal Definition of Myocardial Infarction; 3) the role of point-of-care assays in practice and research; 4) regulatory challenges concerning point-of-care assays; e) testing in the COVID-19 world. SUMMARY: Implementation of high-sensitivity cardiac troponin assays makes a difference now and into the future in clinical practice and research. Providing point-of-care high-sensitivity cardiac troponin assays and optimizing studies to allow clearance of these assays by regulatory agencies, in a timely fashion, may provide improved patient management and outcomes. |*Clinical Chemistry Tests[MESH] |*Point-of-Care Systems[MESH] |Biomarkers/blood[MESH] |COVID-19/epidemiology/virology[MESH] |Humans[MESH] |Limit of Detection[MESH] |Myocardial Infarction/blood/*diagnosis[MESH] |SARS-CoV-2/isolation & purification[MESH] |Troponin I/*blood[MESH]Implementation of High-Sensitivity and Point-of-Care Cardiac Troponin (epmc).pdf DeepDyve Pubget Overpricing